Skip to main content
Journal cover image

30-Day morbidity and mortality of bariatric metabolic surgery in adolescence during the COVID-19 pandemic - The GENEVA study.

Publication ,  Journal Article
Singhal, R; Wiggins, T; Super, J; Alqahtani, A; Nadler, EP; Ludwig, C; Tahrani, A; Mahawar, K; GENEVA Collaborative,
Published in: Pediatr Obes
December 2021

BACKGROUND: Metabolic and bariatric surgery (MBS) is an effective treatment for adolescents with severe obesity. OBJECTIVES: This study examined the safety of MBS in adolescents during the coronavirus disease 2019 (COVID-19) pandemic. METHODS: This was a global, multicentre and observational cohort study of MBS performed between May 01, 2020, and October 10,2020, in 68 centres from 24 countries. Data collection included in-hospital and 30-day COVID-19 and surgery-specific morbidity/mortality. RESULTS: One hundred and seventy adolescent patients (mean age: 17.75 ± 1.30 years), mostly females (n = 122, 71.8%), underwent MBS during the study period. The mean pre-operative weight and body mass index were 122.16 ± 15.92 kg and 43.7 ± 7.11 kg/m2 , respectively. Although majority of patients had pre-operative testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (n = 146; 85.9%), only 42.4% (n = 72) of the patients were asked to self-isolate pre-operatively. Two patients developed symptomatic SARS-CoV-2 infection post-operatively (1.2%). The overall complication rate was 5.3% (n = 9). There was no mortality in this cohort. CONCLUSIONS: MBS in adolescents with obesity is safe during the COVID-19 pandemic when performed within the context of local precautionary procedures (such as pre-operative testing). The 30-day morbidity rates were similar to those reported pre-pandemic. These data will help facilitate the safe re-introduction of MBS services for this group of patients.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Pediatr Obes

DOI

EISSN

2047-6310

Publication Date

December 2021

Volume

16

Issue

12

Start / End Page

e12832

Location

England

Related Subject Headings

  • Treatment Outcome
  • SARS-CoV-2
  • Pandemics
  • Obesity, Morbid
  • Morbidity
  • Male
  • Humans
  • Female
  • COVID-19
  • Bariatric Surgery
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Singhal, R., Wiggins, T., Super, J., Alqahtani, A., Nadler, E. P., Ludwig, C., … GENEVA Collaborative, . (2021). 30-Day morbidity and mortality of bariatric metabolic surgery in adolescence during the COVID-19 pandemic - The GENEVA study. Pediatr Obes, 16(12), e12832. https://doi.org/10.1111/ijpo.12832
Singhal, Rishi, Tom Wiggins, Jonathan Super, Aayed Alqahtani, Evan P. Nadler, Christian Ludwig, Abd Tahrani, Kamal Mahawar, and Kamal GENEVA Collaborative. “30-Day morbidity and mortality of bariatric metabolic surgery in adolescence during the COVID-19 pandemic - The GENEVA study.Pediatr Obes 16, no. 12 (December 2021): e12832. https://doi.org/10.1111/ijpo.12832.
Singhal R, Wiggins T, Super J, Alqahtani A, Nadler EP, Ludwig C, et al. 30-Day morbidity and mortality of bariatric metabolic surgery in adolescence during the COVID-19 pandemic - The GENEVA study. Pediatr Obes. 2021 Dec;16(12):e12832.
Singhal, Rishi, et al. “30-Day morbidity and mortality of bariatric metabolic surgery in adolescence during the COVID-19 pandemic - The GENEVA study.Pediatr Obes, vol. 16, no. 12, Dec. 2021, p. e12832. Pubmed, doi:10.1111/ijpo.12832.
Singhal R, Wiggins T, Super J, Alqahtani A, Nadler EP, Ludwig C, Tahrani A, Mahawar K, GENEVA Collaborative. 30-Day morbidity and mortality of bariatric metabolic surgery in adolescence during the COVID-19 pandemic - The GENEVA study. Pediatr Obes. 2021 Dec;16(12):e12832.
Journal cover image

Published In

Pediatr Obes

DOI

EISSN

2047-6310

Publication Date

December 2021

Volume

16

Issue

12

Start / End Page

e12832

Location

England

Related Subject Headings

  • Treatment Outcome
  • SARS-CoV-2
  • Pandemics
  • Obesity, Morbid
  • Morbidity
  • Male
  • Humans
  • Female
  • COVID-19
  • Bariatric Surgery